|
... Hyperactive Disorder, Artherosclerosis, Asthma, Anti-Infective Prescription Agents, Receptor Blockers, Psychotic Disorders, Osteoporosis, Multiple Sclerosis, Irritable Bowel Syndrome, Insomnia, Immunosupression Hypertension, Epilepsy, Rhinitis, ...
|
|
... Wayne said Thursday it established a new division, FemmePharma mental healthcare, that will focus on central nervous system disorders in women. Since its establishment in 1996, FemmePharma has focused on women's gynecological health issues, ...
|
|
... Global Healthcare, Inc announces the establishment of a new division, FemmePharma Mental Healthcare, Central Nervous System, that will focus on central nervous system (CNS) disorders in women. "We are energized to expand our commitment in women's ...
|
|
... (fesoterodine fumarate) extended-release tablets for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. The NDA approval was granted to Pfizer Inc., New York, USA, which in April ...
|
|
... (fesoterodine fumarate) extended-release tablets for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. The NDA approval was granted to Pfizer Inc., New York, USA, which in April ...
|
|
... of uterine and ovarian cancer Initial symptoms of menopause, the permanent shutting down of the female reproductive system, occur between the ages of 40 and 50 but especially towards 50, said Tyras, adding that the transition period is often coupled ...
|
|
... and trimethoprim, which are used to treat a wide variety of bacterial infections including pneumonia, and urinary tract and intestinal infections -- Antidepressants: fluoxetine, prescribed to treat a variety of conditions, including depression and ...
|